Translating GLP-1 trial outcomes to cardiology practice: which patients will benefit? .

27 August 2018 (13:35 - 13:55)

Organised by:

About the speaker

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Professor T. Luescher (London, GB)

Presentation thumbnail

Diabetes and cardiovascular disease: time for a multifactorial approach.

Professor J. Deanfield (London, GB)

Presentation thumbnail

GLP-1 receptor agonists: the cardiovascular benefits beyond glucose control.

Professor F. Krag Knop (Copenhagen, DK)

Presentation thumbnail

Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Professor J. Deanfield (London, GB) Professor T. Luescher (London, GB)

Access the full session

Session thumbnail

Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)

The Event

ESC Congress 2018

27 August 2018 13:35 CET

You may be interested in

Webinar

Prevention of heart failure in diabetic patients at population level

Congress Session

Diabetes, obesity, and heart failure

Webinar

Diabetes and ACS - enhancing post-discharge outcomes after primary PCI